NETTER-1 phase III : efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate

Strosberg, J. (author)

H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA.

Wolin, E. (author)

Cedars Sinai Med Ctr, Samuel Oschin Canc Ctr, Carcinoid Neuroendocrine Tumor Program, Los Angeles, CA 90048 USA.

Chasen, B. (author)

Univ Kentucky, Markey Canc Ctr, Lexington, KY USA.

show more...

Kulke, M. (author)

Dana Farber Canc Inst, Boston, MA 02115 USA.

Bushnell, D. (author)

Univ Iowa, Iowa City, IA USA.

Chaplin, M. (author)

Royal Free Hosp, London, England.

Baum, R. (author)

Zent Klin Bad Berka, Bad Berka, Germany.

Kunz, P. (author)

Stanford Univ, Med Ctr, Stanford, CA 94305 USA.

Hobday, T. (author)

Mayo Clin, Coll Med, Rochester, MN USA.

Öberg, Kjell (author)

Uppsala universitet,Endokrin tumörbiologi

Sierra, M. Lopera (author)

Adv Accelerator Applicat, New York, NY USA.

Kwekkeboom, D. (author)

Erasmus MC, Rotterdam, Netherlands.

Ruszniewski, P. (author)

Hop Beaujon, Clichy, France.

Krenning, E. (author)

Erasmus MC, Rotterdam, Netherlands.

Hendifar, A. (author)

Cedars Sinai Med Ctr, Samuel Oschin Canc Ctr, Los Angeles, CA 90048 USA.

show less...

H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA Cedars Sinai Med Ctr, Samuel Oschin Canc Ctr, Carcinoid Neuroendocrine Tumor Program, Los Angeles, CA 90048 USA. (creator_code:org_t)

2016

2016

English.

In: Annals of Oncology. - 0923-7534 .- 1569-8041. ; 27, s. 121-121

Related links:

https://urn.kb.se/re...

• Journal article (other academic/artistic)